RT Journal Article
SR Electronic
T1 The Role of PET and PET/CT in Managing the Care of Lymphoma Patients
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 190
OP 194
DO 10.2967/jnmt.110.082982
VO 39
IS 3
A1 Westley C. Evans
A1 David Gilmore
A1 Jeffrey English
YR 2011
UL http://tech.snmjournals.org/content/39/3/190.abstract
AB The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, specifically for Hodgkin disease and aggressive types of non-Hodgkin lymphoma. PET and PET/CT are used to initially stage lymphoma, restage disease, and check for remission or recurrence of malignant tissue after treatment. PET/CT is more sensitive and specific than CT alone and has better accuracy concerning lymphoma relapse and remission. In conjunction with other tests, such as blood laboratory work and biopsy, PET and PET/CT allow the lymphoma to be staged appropriately and treated correctly. Results from PET and PET/CT contribute to the formation of a specialized treatment plan that leads to the best possible care for each individual patient. PET and PET/CT positively affect the management of patients with lymphoma.